IntroductionThis analysis examines the current position and future outlook for Novo Nordisk in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipe ...
Snapshots International | 14 pages | July 2004 | English
Snapdata's UK Digestive Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the UK digestive remedy market, ...
IntroductionAs patent expiries take their toll on small molecule blockbuster drugs Big Pharma are turning to biologic therapies to drive future growth. Alliances and partnerships will be a key stra ...
The metrics in this report cover three year trends in Gelatin: edible, technical, photographic, or pharmaceutical [Manufacturing sector], broken out on a state-by-state basis. Analysis is based on ...
Euromonitor Internationals OTC Cough and Cold Remedies in the UK' Major Market Profile report offers an introduction to the market. It is c. 10 pages long and provides a top line overview of ...
IntroductionCurrently driven by the needs of the expanding respiratory market, the inhalable drug delivery sector has also been invigorated by the promise of growth through the systemic delivery of dr ...
IntroductionThe current ADHD market has long been saturated with traditional methylphenidate and amphetamine based drugs, with the only innovations being the development of extended release versions.< ...
BioInformatics | 176 pages | February 2004 | English
This report will help life science executives decide where to spend their advertising budget using the same criteria as their scientific customers, rather than assessing the value of a portal on the b ...
BCC's goal in conducting this study was to determine the current status of the global diabetes market and assess its growth potential over a 5-year period from 2008 to 2013. Of particular interest ...
IntroductionThe incidence of glioblastoma is increasing. Schering-Plough's temozolomide has gained approval as first line therapy for glioblastoma and has provided some survival benefit. However ...
